Immunovant, Inc. - Common Stock (NQ:IMVT)

34.02 +0.37 (+1.10%)

Delayed Quote Updated: 11:00 AM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Immunovant, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Analyst Expectations for Immunovant's Future ↗

May 23, 2023

Via Benzinga

Recap: Immunovant Q4 Earnings ↗

May 22, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023 ↗

May 01, 2023

Via Benzinga

Analyst Expectations for Immunovant's Future ↗

April 25, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2023 ↗

April 25, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023 ↗

March 31, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023 ↗

March 30, 2023

Via Benzinga

7 Analysts Have This to Say About Immunovant ↗

March 30, 2023

Via Benzinga

Immunovant Inc. (NASDAQ: IMVT) is a Stock Spotlight on 3/24

March 24, 2023

Via Investor Brand Network

Analyst Boosts Immunovant Price Target After Updated Pipeline Realignment ↗

March 20, 2023

Via Benzinga

Analyst Expectations for Immunovant's Future ↗

February 07, 2023

Via Benzinga

Immunovant Could Potentially Be An M&A Target, Writes Analyst ↗

February 15, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2023 ↗

February 15, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 13, 2023 ↗

February 13, 2023

Via Benzinga

Universal Health Services, Madrigal Pharmaceuticals And These Overbought Majors In The Healthcare Sector ↗

December 23, 2022

The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

What 6 Analyst Ratings Have To Say About Immunovant ↗

November 08, 2022

Within the last quarter, Immunovant (NASDAQ:IMVT) has observed the following analyst ratings:

Via Benzinga

6 Analysts Have This to Say About Immunovant ↗

November 08, 2022

Over the past 3 months, 6 analysts have published their opinion on Immunovant (NASDAQ:IMVT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Where Immunovant Stands With Analysts ↗

November 07, 2022

Immunovant (NASDAQ:IMVT) has observed the following analyst ratings within the last quarter:

Via Benzinga

Immunovant to Present at Guggenheim 4th Annual Immunology and Neurology Day on November 14th

November 07, 2022

From Immunovant Inc.

Via GlobeNewswire

Immunovant: Q2 Earnings Insights ↗

November 04, 2022

Immunovant (NASDAQ:IMVT) reported its Q2 earnings results on Friday, November 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Why Immunovant Stock Is Skyrocketing This Week ↗

October 06, 2022

The drugmaker announced a $75 million public offering.

Via The Motley Fool

Immunovant Reports Financial Results and Recent Business Updates for the Quarter Ended September 30, 2022

November 04, 2022

From Immunovant Inc.

Via GlobeNewswire

Why Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterday ↗

October 06, 2022

Gainers Chardan NexTech Acquisition 2 Corp. (NASDAQ: CNTQ) shares surged 102.6% to close at $21.54 on Wednesday.

Via Benzinga

Why Sotera Health Shares Are Trading Lower By Around 13%, Here Are 38 Stocks Moving In Wednesday's Mid-Day Session ↗

October 05, 2022

Gainers Pineapple Energy Inc. (NASDAQ: PEGY) shares jumped 104% to $2.9201. Shares of this low-float penny stock closed up about 80% on Tuesday.

Via Benzinga

RPM International, Lamb Weston And Some Other Big Stocks Moving Higher On Wednesday ↗

October 05, 2022

U.S. stocks traded lower, with the Dow Jones dropping more than 300 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

S&P 500 Rises 100 Points; Nasdaq Up 3% ↗

October 04, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing more than 300 points on Tuesday.

Via Benzinga

R&D Efforts to Improve Optimal Treatments for Advanced Pancreatic Ductal Adenocarcinoma (PDAC) Progressing

October 05, 2022

Palm Beach, FL – October 5, 2022 – FinancialNewsMedia.com News Commentary – Advanced pancreatic ductal adenocarcinoma (PDAC) remains a significant cause of mortality accounting for up to 4% of all...

Via FinancialNewsMedia

Topics Death

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 04, 2022

Gainers

Via Benzinga

Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session ↗

October 04, 2022

Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday.

Via Benzinga

Nasdaq Surges 350 Points; Crude Oil Rises Sharply ↗

October 04, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq Composite climbing more than 350 points on Tuesday.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.